CAS Number: 1622-61-3
Molecular Weight: 315.711
Method of Analysis: BP
Lennox-Gastaut syndrome (petit mal variant), Akinetic, myoclonic seizures, Burning Mouth Syndrome
Clonazepam enhances the activity of the inhibitory neurotransmitter Gamma-Aminobutyric acid (GABA) in the central nervous system to give its anticonvulsant, skeletal muscle relaxant, and anxiolytic effects. It acts by binding to the benzodiazepine site of the GABA receptors, which enhances the electric effect of GABA binding on neurons, resulting in an increased influx of chloride ions into the neurons. This further results in an inhibition of synaptic transmission across the central nervous system.
Preserve in well-closed, light resistanat containers, store below 30˚C,protected from light
The final product is packed in polyethylene nylon plastic bag and then packaged in a 3-layeredaluminum foil.